Attached files

file filename
10-Q/A - AMENDMENT NO. 2 TO FORM 10-Q - Anixa Biosciences Incd263130d10qa.htm
EX-10.2 - LICENSE AGREEMENT - Anixa Biosciences Incd263130dex102.htm
EX-10.1 - EXCLUSIVE LICENSE AGREEMENT - Anixa Biosciences Incd263130dex101.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Incd263130dex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Incd263130dex312.htm
EX-32.1 - STATEMENT OF CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 1350 OF TITLE 18 - Anixa Biosciences Incd263130dex321.htm

Exhibit 32.2

Statement of Chief Financial Officer

Pursuant to Section 1350 of Title 18 of the United States Code

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Henry P. Herms, the Vice President - Finance and Chief Financial Officer of CopyTele, Inc., hereby certifies that:

 

  1. The Company’s Form 10-Q/A Quarterly Report (Amendment No. 2) for the period ended July 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

   

/s/ Henry P. Herms

    Henry P. Herms
November 30, 2011     Vice President - Finance and Chief Financial Officer